EP 0749313 A4 20011024 - METHOD FOR TREATING 5HT 2B RECEPTOR RELATED CONDITIONS
Title (en)
METHOD FOR TREATING 5HT 2B RECEPTOR RELATED CONDITIONS
Title (de)
VERFAHREN ZUR BEHANDLUNG VON MIT DEM 5-HT2B-REZEPTOR VERBUNDENEN ZUSTÄNDEN
Title (fr)
METHODE DE TRAITEMENT D'ETATS ASSOCIES AU RECEPTEUR 5HT 2B
Publication
Application
Priority
- US 9503099 W 19950310
- US 21262294 A 19940311
- US 38056695 A 19950206
- US 38056595 A 19950206
Abstract (en)
[origin: WO9524200A1] The present invention provides methods for binding a 5-HT2B receptor in mammals using both known and novel compounds. Further, the invention provides a method for treating or preventing 5-HT2B related conditions. Finally, the invention provides an article of manufacture.
IPC 1-7
C07D 471/04; C07D 209/16; C07D 457/04; C07D 457/06; C07D 241/04; C07D 403/12; C07D 261/08; A61K 31/551
IPC 8 full level
C07D 239/26 (2006.01); A61K 31/40 (2006.01); A61K 31/403 (2006.01); A61K 31/404 (2006.01); A61K 31/42 (2006.01); A61K 31/435 (2006.01); A61K 31/437 (2006.01); A61K 31/44 (2006.01); A61K 31/4418 (2006.01); A61K 31/4427 (2006.01); A61K 31/475 (2006.01); A61K 31/48 (2006.01); A61K 31/495 (2006.01); A61K 31/496 (2006.01); A61K 31/505 (2006.01); A61K 31/55 (2006.01); A61P 1/10 (2006.01); A61P 1/12 (2006.01); A61P 9/08 (2006.01); A61P 9/10 (2006.01); A61P 11/00 (2006.01); A61P 13/02 (2006.01); A61P 15/00 (2006.01); A61P 43/00 (2006.01); C07D 209/14 (2006.01); C07D 209/16 (2006.01); C07D 209/60 (2006.01); C07D 213/65 (2006.01); C07D 261/08 (2006.01); C07D 261/10 (2006.01); C07D 295/096 (2006.01); C07D 307/81 (2006.01); C07D 401/12 (2006.01); C07D 471/04 (2006.01); C07D 471/06 (2006.01)
CPC (source: EP)
A61K 31/40 (2013.01); A61K 31/42 (2013.01); A61K 31/437 (2013.01); A61K 31/44 (2013.01); A61K 31/475 (2013.01); A61K 31/48 (2013.01); A61K 31/495 (2013.01); A61K 31/55 (2013.01); A61P 1/10 (2017.12); A61P 1/12 (2017.12); A61P 9/08 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); A61P 13/02 (2017.12); A61P 15/00 (2017.12); A61P 43/00 (2017.12); C07D 209/14 (2013.01); C07D 209/60 (2013.01); C07D 295/096 (2013.01); C07D 471/06 (2013.01)
Citation (search report)
- [X] US 3492304 A 19700127 - SHAVEL JOHN JR, et al
- [PX] US 5300645 A 19940405 - AUDIA JAMES E [US], et al
- [PX] EP 0620222 A2 19941019 - LILLY CO ELI [US]
- [A] US 4731358 A 19880315 - HUTH ANDREAS [DE], et al
- [A] MARTIN G R ET AL: "RECEPTORS FOR 5-HYDROXYTRYPTAMINE: CURRENT PERSPECTIVES ON CLASSIFICATION AND NOMENCLATURE", NEUROPHARMACOLOGY,GB,PERGAMON PRESS, OXFORD, vol. 33, no. 3/04, 1 March 1994 (1994-03-01), pages 261 - 273, XP002037183, ISSN: 0028-3908
- [A] GLENNON, R. A.: "Central Serotonin Receptors as Targets for Drug Research", J. MED. CHEM., vol. 30, 1987, pages 1 - 12, XP002167538
- [X] SPÄTH, E. ET AL: "SYNTHESEN VON 4-CARBOLINEN", CHEMISCHE BERICHTE,XX,XX, vol. 120, 18 July 1930 (1930-07-18), pages 2102 - 2111, XP000917524, ISSN: 0009-2940
- [X] ONDA, M.; KAWANISHI, M.: "Analogs of Rauwolfia Alkaloids", J. PHARM. SOC. JPN., vol. 76, 1956, pages 966 - 968, XP000985848
- [T] AUDIA, J. E. ET AL.: "Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B contractile receptor in the rat stomach fundus", J. MED. CHEM., vol. 39, 1996, pages 2773 - 2780, XP002167539
- See references of WO 9524200A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9524200 A1 19950914; AU 2118695 A 19950925; AU 679635 B2 19970703; CA 2185236 A1 19950914; CN 1148340 A 19970423; CZ 264996 A3 19980114; EP 0749313 A1 19961227; EP 0749313 A4 20011024; FI 963571 A0 19960910; FI 963571 A 19961108; HU 9602482 D0 19961128; HU T75522 A 19970528; IL 112958 A0 19950629; JP H09510216 A 19971014; NO 963785 D0 19960910; NO 963785 L 19961101
DOCDB simple family (application)
US 9503099 W 19950310; AU 2118695 A 19950310; CA 2185236 A 19950310; CN 95193029 A 19950310; CZ 264996 A 19950310; EP 95914014 A 19950310; FI 963571 A 19960910; HU 9602482 A 19950310; IL 11295895 A 19950310; JP 52369295 A 19950310; NO 963785 A 19960910